Preview

Creative surgery and oncology

Advanced search

Bowen's Disease: Literature Review

https://doi.org/10.24060/2076-3093-2023-13-1-68-76

Abstract

The paper presents the results of the bibliographic research materials on Bowen's disease over the past 15 years. The aetiopathogenesis of the disease is not yet fully understood; however, most experts designate the following trigger factors: prolonged use of drugs that suppress the immune response, human papillomavirus, light skin type, and excessive exposure to sunlight, ionizing radiation, arsenic intake. Clinical manifestations of Bowen's disease take anular, verrucous, pigmented, and acral forms. Atypical variants of the disease include “giant” Bowen's disease, and cases of localization of lesions on the face. The paper describes the clinical symptoms of each clinical form of Bowen's disease, diagnostic methods, and various treatment methods used in foreign and domestic practice. Comparative results of research on the treatment methods of Bowen's disease include such methods as surgical removal, Mohs micrographic surgery, photodynamic therapy, curettage, cryotherapy, laser ablation, radiation therapy as well as conservative treatment methods. The latter include topical application of external remedies (fluorouracil, imiquimod, diclofenac), as they can be quite effective in certain cases. The advantages of photodynamic therapy are indicated both in terms of high efficiency and in the safety spectrum of treatment of Bowen's disease.

About the Authors

Z. R. Khismatullina
Bashkir State Medical University
Russian Federation

Zarema R. Khismatullina — Dr. Sci. (Med.), Prof., Department of Dermatovenerology with Courses of Dermatovenerology and Cosmetology for Advanced Professional Education

Ufa



E. V. Lipova
A.I. Burnasyan Federal Medical Biophysical Center FMBA
Russian Federation

Elena V. Lipova — Dr. Sci. (Med.), Prof., Department of Dermatovenerology and Cosmetology with a Course of Clinical Laboratory Diagnostics

Moscow



A. A. Khammatova
Republican Dermatovenereal Dispensary
Russian Federation

Alsu A. Khammatova — Dermatology Unit No. 1

Ufa



M. I. Khabibullina
Bashkir State Medical University
Russian Federation

Milyausha I. Khabibullina — Department of Dermatovenerology with Courses of Dermatovenerology and Cosmetology for Advanced Professional Education

Ufa



E. Najafizade
Bashkir State Medical University
Russian Federation

Elakhe Najafizade — Department of Dermatovenerology with Courses of Dermatovenerology and Cosmetology for Advanced Professional Education

Ufa



K. Z. Ianbarisova
Bashkir State Medical University
Russian Federation

Kamilla Z. Ianbarisova — 6th year Student

Ufa



References

1. Molina-García M., Malvehy J., Granger C., Garre A., Trullàs C., Puig S. Exposome and skin. Part 2. The influential role of the exposome, beyond UVR, in actinic keratosis, Bowen's disease and squamous cell carcinoma: a proposal. Dermatol Ther (Heidelb). 2022;12(2):361–80. DOI: 10.1007/s13555-021-00644-3

2. Azimi A., Yang P., Ali M., Howard V., Mann G.J., Kaufman K.L., et al. Data independent acquisition proteomic analysis can discriminate between actinic keratosis, Bowen's disease, and cutaneous squamous cell carcinoma. J Invest Dermatol. 2020;140(1):212–22.e11. DOI: 10.1016/j.jid.2019.06.128

3. de Jong E., Lammerts M.U.P.A., Genders R.E., Bouwes Bavinck J.N. Update of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol. 2022;36 Suppl 1(Suppl 1):6–10. DOI: 10.1111/jdv.17728

4. Hama N., Ohtsuka T., Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen’s disease and squamous cell carcinoma of the skin. J Dermatol 2006;33:331–7. DOI: 10.1111/j.1346-8138.2006.00078.x

5. Jiang K.W., Zhao C.Y., Chan C., Peduto M.Y., Kailainathan G., Cook D.K. Eruptive Bowen's disease in a patient on pembrolizumab for Hodgkin's lymphoma. Australas J Dermatol. 2021;62(3):e435–7. DOI: 10.1111/ajd.13652

6. Drake A.L., Walling H.W. Variations in presentation of squamous cell carcinoma in situ (Bowen’s disease) in immunocompromised patients. J Am Acad Dermatol. 2008;59:68–71. DOI: 10.1016/j.jaad.2008.03.028

7. Hampton S., Timmis J. Actinic keratosis and Bowen's disease: case of a Leg Club member. Br J Community Nurs. 2020;25(Sup12):S39–40. DOI: 10.12968/bjcn.2020.25.Sup12.S39

8. Chung J.Y., Yu S.D., Hong Y.S. Environmental source of arsenic exposure. J Prev Med Public Health. 2014;47(5):253–7. DOI: 10.3961/jpmph.14.036

9. Yu H.S., Liao W.T., Chai C.Y. Arsenic carcinogenesis in the skin. J Biomed Sci. 2006;13(5):657–66. DOI: 10.1007/s11373-006-9092-8

10. Morton C.A., Birnie A.J., Eedy D.J. British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014. Br J Dermatol. 2014;170:245–60. DOI:10.1111/bjd.12766

11. Lacarrubba F., Verzì A.E., Caltabiano R., Micali G. Bowen's disease of the penile shaft presenting as a pigmented macule: dermoscopy, reflectance confocal microscopy and histopathological correlation. An Bras Dermatol. 2021;96(5):609–12. DOI: 10.1016/j.abd.2020.10.009

12. Jansen P., Baguer D.O., Duschner N., Le'Clerc Arrastia J., Schmidt M., Wiepjes B., et al. Evaluation of a deep learning approach to differentiate Bowen's disease and seborrheic keratosis. Cancers (Basel). 2022;14(14):3518. DOI: 10.3390/cancers14143518

13. Palaniappan V., Karthikeyan K. Bowen's Disease. Indian Dermatol Online J. 2022;13(2):177–89. DOI: 10.4103/idoj.idoj_257_21

14. Liang D.G., Soliman B., Cha J. A rare case of Bowen's disease of the nipple: Literature review and management pathway. Breast J. 2020;26(6):1234–8. DOI: 10.1111/tbj.13824

15. Chan S.L., Watchorn R.E., Panagou E., Panou E., Ong E.L., Heelan K., et al. Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat. Australas J Dermatol. 2019;60(3):e201–7. DOI: 10.1111/ajd.12981

16. Mishra J., Pandia A., Padhy A.K., Mahapatra M., Mohapatra J., Nayak B., et al. Bowen's disease of vulva: A rare case of vulvar premalignant disorder. Clin Cancer Investig J. 2020;9(5):210. DOI: 10.4103/ccij.ccij_61_20

17. Nagakeerthana S., Rajesh G., Madhavi S., Karthikeyan K. Bowen's disease: Two case reports of a giant and dwarf lesions. J Can Res Ther. 2017;13(2):371–3. DOI: 10.4103/0973-1482.187237

18. Ianosi S.L., Batani A., Ilie M.A., Tampa M., Georgescu S.R., Zurac S., et al. Non-invasive imaging techniques for the in vivo diagnosis of Bowen's disease: Three case reports. Oncol Lett. 2019;17(5):4094–101. DOI: 10.3892/ol.2019.10079

19. Morton C.A., Whitehurst C., McColl J.H., Moore J.V., MacKie R.M. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137(3):319–24. PMID: 11255332

20. Lopez N., Meyer-Gonzalez T., Herrera-Acosta E., Bosch R., Castillo R., Herrera E. Photodynamic therapy in the treatment of extensive Bowen's disease. J Dermatolog Treat. 2012;23(6):428–30. DOI: 10.3109/09546634.2011.590789

21. Mazilli S., Gamo-Villegas R., Pampin-Franco A., Lopez Estebaran J.L., Pinedo F., Vollono L., et al. Reflectance confocal microscopy of pigmented Bowen's disease: A Case series of difficult to diagnose lesions. Case Rep Dermatol. 2020;12(2):98–106. DOI: 10.1159/000507916

22. Neagu T.P., Ţigliş M., Botezatu D., Enache V., Cobilinschi C.O., Vâlcea-Precup M.S., et al. Clinical, histological and therapeutic features of Bowen’s disease. Rom J Morphol Embryol. 2017;58(1):33–40. PMID: 28523295

23. Yang Y., Lin J., Fang S., Han S., Song Z. What’s new indermoscopy of Bowen’s disease: Two new dermoscopic signs and its differential diagnosis. Int J Dermatol. 2017;56(10):1022–5. DOI: 10.1111/ijd.13734

24. Wozniak-Rito A.M., Rudnicka L. Bowen's disease in dermoscopy. Acta Dermatovenerol Croat. 2018;26(2):157–61. PMID: 29989873

25. Narahira A., Yanagi T., Kitamura S., Hata H., Shimizu H. Dermoscopic features of genital pigmented Bowen's disease: Report of a case and review of the published work. J Dermatol. 2019;46(10):e390–1. DOI: 10.1111/1346-8138.14938

26. Leibovitch I., Huilgol S.C., Selva D., Richards S., Paver R. Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(6):997–1002. DOI: 10.1016/j.jaad.2004.12.033

27. Luo Z., Chen M., Su J., Chen X., Zhao S. A case of bowenoid papulosis treated with sequential curettage and photodynamic therapy. Photodermatol Photoimmunol Photomed. 2020;36(3):251–3. DOI: 10.1111/phpp.12540

28. Sharma A., Birnie A.J., Bordea C., Cheung S.T., Mann J., Morton C.A., et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022. Br J Dermatol. 2023;00:1–9. DOI: 10.1093/ bjd/ljac042

29. Hansen J.P., Drake A.L., Walling H.W. Bowen’s disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg. 2008; 34(7):878–83. DOI: 10.1111/j.15244725.2008.34172.x

30. Ahmed I., Berth-Jones J., Charles-Holmes S., O'Callaghan C.J., Ilchyshyn A. Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study. Br J Dermatol. 2000;143(4):759–66. DOI: 10.1046/j.1365-2133.2000.03772.x

31. Morton C.A., Whitehurst C., Moseley H., McColl J.H., Moore J.V., Mackie R.M. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135(5):766–71. PMID: 8977678

32. Genouw E., Verheire B., Ongenae K., De Schepper S., Creytens D., Verhaeghe E., et al. Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode. J Eur Acad Dermatol Venereol. 2018;32(11):1897–905. DOI: 10.1111/jdv.14989

33. Tantikun N. Treatment of Bowen's disease of the digit with carbon dioxide laser. J Am Acad Dermatol. 2000;43(6):1080–3. DOI: 10.1067/ mjd.2000.109841

34. Covadonga Martínez-González M., del Pozo J., Paradela S., Fernández-Jorge B., Fernández-Torres R., Fonseca E. Bowen's disease treated by carbon dioxide laser. A series of 44 patients. J Dermatolog Treat. 2008;19(5):293–9. DOI: 10.1080/09546630701870772

35. Fader D.J., Lowe L. Concomitant use of a high-energy pulsed CO2 laser and a long-pulsed (810 nm) diode laser for squamous cell carcinoma in situ. Dermatol Surg. 2019;28(1):97–9. DOI: 10.1046/j.15244725.2002.01091.x

36. Zygogianni A., Kouvaris J., Tolia M., Kyrgias G., Beli I., Kantzou I., et al. The potential role of radiation therapy in Bowen's disease: a review of the current literature. Rev Recent Clin Trials. 2012;7(1):42–6. DOI: 10.2174/157488712799363271

37. McKenna D.J., Morris S., Kurwa H. Treatment-resistant giant unilateral Bowen’s disease of the scalp responding to radiotherapy. Clin Exp Dermatol. 2016;34(1):85–6. DOI: 10.1111/j.1365-2230.2008.02757.x

38. Herman J.M., Pierce L.J., Sandler H.M., Griffith K.A., Jabbari S., Hiniker S.M., et al. Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. Radiother Oncol. 2008;88(3):398–402. DOI: 10.1016/j.radonc.2008.05.025

39. Cox N.H. Bowen’s disease: where now with therapeutic trials? Br J Dermatol. 2000;143:699–700. DOI: 10.1046/j.13652133.2000.03819.x

40. Park H.E, Park J.W., Kim Y.H, Han J.H., Bang C.H., Park Y.M., et al. Analysis on the effectiveness and characteristics of treatment modalities for Bowen's Disease: an observational study. J Clin Med. 2022;11(10):2741. DOI: 10.3390/jcm11102741

41. Mo Y.W., Lee D.L. Comparison of the recurrence rate of 3 treatment modalities for Bowen disease in an aging city: A retrospective multivariate analysis. Medicine (Baltimore). 2020;99(27):e19893. DOI: 10.1097/MD.0000000000019893

42. Jansen M.H., Appelen D., Nelemans P.J., Winnepenninckx V.J., Kelleners-Smeets N.W.J., Mosterd K. Bowen's disease: long-term results of treatment with 5-fluorouracil cream, photodynamic therapy or surgical excision. Acta Derm Venereol. 2018;98(1):114–5. DOI: 10.2340/00015555-2777

43. Zhong S., Zhang R., Mei X., Wang L. Efficacy of photodynamic therapy for the treatment of Bowen's disease: An updated systematic review and meta-analysis of randomized controlled trials. Photodiagnosis Photodyn Ther. 2020;32:102037. DOI: 10.1016/j.pdpdt.2020.102037

44. Gaitanis G., Bassukas I.D. Immunocryosurgery — an effective combinational modality for Bowen's disease. Dermatol Ther. 2016;29(5):334– 7. DOI: 10.1111/dth.12371

45. Morton C., Horn M., Leman J., Tack B., Bedane C., Tjioe M., et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol. 2006;142(6):729–35. DOI: 10.1001/archderm.142.6.729

46. Mohanna M.T., Hofbauer G.F. Bowenoid actinic keratosis and Bowen's disease treated successfully with ingenol mebutate. Dermatology. 2016;232 Suppl 1:14–6. DOI: 10.1159/000447390

47. Gomez C., Cobos M., Alberdi E. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions. Photodiagnosis Photodyn Ther. 2019;26:295–9. DOI: 10.1016/j.pdpdt.2019.04.011

48. Morton C.A., Szeimies R.M., Basset-Seguin N., Calzavara-Pinton P., Gilaberte Y., Haedersdal M., et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications — actinic keratoses, Bowen's disease and basal cell carcinomas. J Eur Acad Dermatol Venereol. 2019;33(12):2225–38. DOI: 10.1111/jdv.16017

49. Aguilar-Bernier M., Rodríguez-Barón D., Rivas-Ruiz F., Segura-Palacios J.M., de Troya Martín M. Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen’s disease in clinical practice: A retrospective cohort study (2006–2017). Photodermatol Photoimmunol Photomed. 2019;35(4):208–13. DOI: 10.1111/phpp.12453

50. O'Connell K.A., Okhovat J.P., Zeitouni N.C. Photodynamic therapy for Bowen's Disease (squamous cell carcinoma in situ) current review and update. Photodiagnosis Photodyn Ther. 2018;24:109–14. DOI: 10.1016/j.pdpdt.2018.09.009

51. Xue W.L., Ruan J.Q., Liu H.Y., He H.X. Efficacy of photodynamic therapy for the treatment of Bowen's disease: a meta-analysis of randomized controlled trials. Dermatology. 2022;238(3):542–50. DOI: 10.1159/000519319

52. Robustelli Test E., Fumo G., Corbeddu M., Ferreli C., Rongioletti F. Efficacy of Imiquimod 3.75 % for the treatment of extensive Bowen's disease of the face in an elderly patient. Dermatol Ther. 2020;33(2):e13263. DOI: 10.1111/dth.13263

53. Provini A., Ruggeri S., Mazzanti C., Pilla M.A., Ricci F., Panebianco A., et al. Successful treatment of two cases of perianal Bowen disease with photodynamic therapy followed by imiquimod cream. Dermatol Ther. 2020;33(4):e13759. DOI: 10.1111/dth.13759

54. Lo T.K., Chen Y.C., Liu W.T., Wong T.W. Successful treatment of giant Bowen's disease with photodynamic therapy and subsequent imiquimod in a case with chronic arsenic exposure. Photodiagnosis Photodyn Ther. 2022;40:103128. DOI: 10.1016/j.pdpdt.2022.103128


Review

For citations:


Khismatullina Z.R., Lipova E.V., Khammatova A.A., Khabibullina M.I., Najafizade E., Ianbarisova K.Z. Bowen's Disease: Literature Review. Creative surgery and oncology. 2023;13(1):68-76. (In Russ.) https://doi.org/10.24060/2076-3093-2023-13-1-68-76

Views: 2157


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2076-3093 (Print)
ISSN 2307-0501 (Online)